iPS cells derived from HIV-resistant individuals for the treatment of HIV infection

New technique: It involves iPS cells from HIV-resistant individuals for the treatment of people infected  Some people have a mutation in their genome (CCR5A32) that gives them certain resistance to HIV infection. Taking advantage of this situation, a step has now been taken that...